You don't need to be signed in to listen to BMJ Group Podcasts, but you can register here to receive updates about other BMJ Group products and services via our Group site.

Journal Club: Predicting survival in resected non-small-cell lung cancer

2 Nov, 12 | by BMJ Group

Jennifer Quint, Thorax’s Journal Club editor, talks to David Jablons, University of California San Francisco, and consultant for Life Technologies, about his assay to predict survival in resected non-squamous, non-small-cell lung cancer.

See also:
A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies

Journal Club: Predicting survival in resected non-small-cell lung cancer:
Play Now
Play in Popup
Download
Posted in Journal club.
Respond
Print page

Leave a Reply

You can follow any responses to this entry through the RSS 2.0 feed.
« Journal Club: Outcomes after thoracoscopic versus open lobectomy
Journal club: Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis »

Latest from Heart

Latest from Heart